AR and posterior cortical atrophy: Among patients with or without AR antagonists or chemotherapy use (N = 876 and N = 1096, respectively), metformin users had significantly lower risks of PCa‐related mortality and all‐cause mortality, with stronger associations observed in patients without AR antagonist or chemotherapy use (p value for interaction = 0.017 and 0.048, respectively; Table 2).